Our aim was to investigate the regulation of the gene expression of leptin in subcutaneous adipose tissue biopsies in morbid obesity before and after biliopancreatic diversion (BPD).
Methods
Longitudinal study in morbidly obese subjects investigated twice: before and 6 months after BPD. Fourteen morbidly obese women, 37±13 years old and with a body mass index of 51.6±8.2 kg/m2, were studied before and 6 months after BPD (40.6±8.0 kg/m2). Using reverse transcriptase polymerase chain reaction analysis, the mRNA expression of leptin was investigated in adipose tissue. Plasma leptin was measured by radioimmunoassay; plasma insulin was measured by microparticle enzyme immunoassay. Free fatty acids (FFA) were measured using a colorimetric kit.
Results
A significant decrease in leptin mRNA level was observed in comparison with pretreatment in BPD patients (59±34 vs 143±85 arbitrary units, P <0.01). A strict relationship between adipose tissue leptin mRNA and plasma leptin either before (R2=0.80, P <0.0001) or after BPD (R2=0.86, P <0.0001) and between plasma FFA concentration and insulin either before (R2=0.65, P <0.001) or after BPD (R2=0.92, P <0.0001) was observed. Finally, a significant correlation was found between changes in FFA and insulin (R2=0.64, P <0.001), insulin and leptin (R2=0.88, P <0.0001), and insulin and leptin mRNA (R2=0.83, P <0.0001).
Conclusion
These data demonstrate a high correlation between leptin mRNA expression in adipose tissue and plasma leptin in postobese subjects after BPD. The significant relationship between both leptin mRNA and plasma leptin with insulin suggests that circulating insulin might regulate leptin expression. It might be hypothesized that plasma FFA concentration can act on the insulin secretion and subsequently on the leptin secretory pathway.
HalaasJL, GajiwalaKS, MaffeiM, CohenSL, ChaitBT, RabinowitzD, LalloneRL, BurleySK, FriedmanJM.Weight-reducing effects of the plasma protein encoded by the obese gene. Science1995;269:543–546.
2.
ConsidineRV, SinhaMK, HeimanML, KriauciunasA, StephensTW, NyceMR, OhannesianJP, MarcoCC, McKeeLJ, BauerTL, CaroJF.Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med1996;334:292–295.
3.
MontagueCT, PrinsJB, SandersL, DigbyJE, O/RahillyS.Depot- and sex-specific differences in human leptin mRNA expression: Implications for the control of regional fat distribution. Diabetes1997;46:342–347.
4.
LonnqvistF, ThomeA, NilsellK, HoffstedtJ, ArnerP.A pathogenic role of visceral fat β-3-adrenoceptors in obesity. J Clin Invest1995;95:1109–1116.
5.
MaffeiM, HalaasJ, RavussinE, PratleyRE, LeeGH, ZhangY, FeiH, KimS, LalloneR, RanganathanS, KernPA, FriedmanJM.Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med1995;1:1155–1161.
6.
WingRR, SinhaMK, ConsidineRV, LangW, CaroJF.Relationship between weight loss maintenance and changes in serum leptin levels. Horm Metab Res1996;28:698–703.
7.
KolaczynskiJW, ConsidineRV, OhannesianJ, MarcoC, OpentanovaI, NyceMR, MyintM, CaroJF.Responses of leptin to short-term fasting and refeeding in humans: A link with ketogenesis but not ketones themselves. Diabetes1996;45:1511–1515.
8.
SinhaMK, OpentanovaI, OhannesianJP, KolaczynskiJW, HeimanML, HaleJ, BeckerGW, BowsherRR, StephensTW, CaroJF.Evidence of free and bound leptin in human circulation: Studies in lean and obese subjects and during short-term fasting. J Clin Invest1996;98:1277–1282.
9.
WaddenTA, ConsidineRV, FosterGD, AndersonDA, SarwerDB, CaroJS.Short- and long-term changes in serum leptin dieting obese women: Effects of caloric restriction and weight loss. J Clin Endocrinol Metab1998;83:214–218.
10.
AdamiGF, CorderaR, CampostanoA, BressaniA, CellaF, ScopinaroN.Serum leptin and weight loss in severely obese patients undergoing biliopancreatic diversion. Int J Obes Relat Metab Disord1998;22:822–824.
11.
De MarinisL, ManciniA, ValleD, BianchiA, MilardiD, ProtoA, LanzoneA, TacchinoR.Plasma leptin levels after biliopancreatic diversion: Dissociation with body mass index. J Clin Endocrinol Metab1999;84:2386–2389.
12.
MarinariGM, CameriniG, CellaF, ScopinaroN, AdamiGF.Short-term changes in serum leptin concentration following biliopancreatic diversion. Obes Surg2000;10:442–444.
13.
TataranniPA, MingroneG, GrecoAV, CaradonnaP, CapristoE, RagusoCA, De GaetanoA, TacchinoRM, CastagnetoM.Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion. Am J Clin Nutr1994;60:320–326.
14.
CastagnetoM, De GaetanoA, MingroneG, TacchinoR, NanniG, CapristoE, BenedettiG, TataranniPA, GrecoAV.Normalization of insulin sensitivity in the obese patient after stable weight reduction with biliopancreatic diversion. Obes Surg1994;4:161–168.
15.
TataranniPA, MingroneG, RagusoCA, DeGaetanoA, TacchinoRM, CastagnetoM, GrecoAV.Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversion. Nutrition1996;12:239–244.
16.
MingroneG, DeGaetano A, GrecoAV, CapristoE, BenedettiG, CastagnetoM, GasbarriniG.Reversibility of insulin resistance in obese diabetic patients: Role of plasma lipids. Diabetologia1997;40:599–605.
17.
ScopinaroN, GianettaE, CivalleriD, BonalumiU, BachiV.Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg1979;66:618–620.
18.
ScopinaroN, AdamiGF, MarinariGM, TraversoE, ParadiaF, CameriniG.Biliopancreatic diversion: Two decades of experience. In:DeitelM, CowanGSMJr(Eds): Surgery for the Morbidly Obese Patient. Toronto: FD-Communication, Inc., 2000, pp.227–258.
19.
MooreFD, OlesenKH, McMurreyJD, ParkerHV, BallMR, BoydenCM.The Body Cell Mass and Its Supporting Environment: Body Composition in Health and Disease.Philadelphia: W.B. Saunders Co., 1963.
20.
CulebrasJM, MooreFD.Total body water and the exchangeable hydrogen: I. Theoretical calculation of nonaqueous exchangeable hydrogen in man. Am J Physiol1977;232:R54–R59.
21.
HeymsfieldSB, LichtmanS, BaumgartnerRN, WangJ, KamenY, AliprantisA, PiersonRNJr.Body composition of humans: Comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr1990;52:52–58.
22.
BonoraE, DelPrato S, BonadonnaRC,GulliG,SoliniA, ShankML, GhiatasAA, LancasterJL, KilcoyneRF, AlyassinAM, DeFronzoRA.Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes1992;41:1151–1159.
23.
NisoliE, CarrubaMO, TonelloC, MacorC, FederspilG, VettorR.Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-γ2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-α gene expression in human subcutaneous fat by lipid infusion. Diabetes2000;49:319–324.
24.
ClémentK, VaisseC, LahlouN, CabrolS, PellouxV, CassutoD, GourmelenM, DinaC, ChambazJ, LacorteJM, BasdevantA, BougneresP, LeboucY, FroguelP, Guy-GrandB. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature1998;392:398–401.
25.
HavelPJ, Kasim-KarakasS,MuellerW, JohnsonPR, GingerichRL, SternJS.Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab1996;81:4406–4413.
26.
HwaJJ, FawziAB, GrazianoMP, GhibaudiL, WilliamsP, VanHeek M,DavisH, RudinskiM, SybertzE,StraderCD.Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol1997;272:R1204–R1209.
27.
HarrisRB, RamsayTG, SmithSR, BruchRC.Early and late stimulation of ob mRNA expression in meal-fed and overfed rats. J Clin Invest1996;97:2020–2026.
28.
GuvenS, El-BershawiA, SonnenbergGE, WilsonCR, HoffmannRG, KrakowerGR, KissebahAH.Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: Relationships with body composition and insulin. Diabetes1999;48:347–352.
29.
MaffeiM, HalaasJ, RavussinE, PratleyRE, LeeGH, ZhangY, FeiH, KimS, LalloneR, RanganathanS, KernPA, FriedmanJM.Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med1995;1:1155–1161.
30.
ConsidineRV, SinhaMK, HeimanML, KriauciunasA, StephensTW, NyceMR, OhannesianJP, MarcoCC, McKeeLJ, BauerTL, CaroJF.Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med1996;334:292–295.
31.
MuellerWM, GregoireFM, StanhopeKL, MobbsCV, MizunoTM, WardenCH, SternJS, HavelPJ.Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology1998;139:551–558.
32.
CarantoniM, AbbasiF, AzharS, ChenYD, KlebanovM, WangPW, WarmerdamF, ReavenGM.Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance. Diabetes1998;47:244–247.
33.
KolaczynskiJW, OhannesianJP, ConsidineRV, MarcoCC, CaroJF.Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab1996;81:4162–4165.
34.
VidalH, AuboeufD, De VosP, StaelsB, RiouJP, AuwerxJ, LavilleM.The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest1996;98:251–255.
35.
CarantoniM, AbbasiF, AzharS, SchaafP, ReavenGM.Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?J Clin Endocrinol Metab1999;84:869–872.
36.
BarrVA, MalideD, ZarnowskiMJ, TaylorSI, CushmanSW.Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology1997;138:4463–4472.
37.
MacDougaldOA, HwangCS, FanH, LaneMD.Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A1995;92:9034–9037.
38.
LeroyP, DessolinS, VillageoisP, MoonBC, FriedmanJM, AilhaudG, DaniC.Expression of ob gene in adipose cells: Regulation by insulin. J Biol Chem1996;271:2365–2368.
39.
RentschJ, ChiesiM.Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett1996;379:55–59.
40.
BeckerDJ, OngembaLN, BrichardV, HenquinJC, BrichardSM.Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett1995;371:324–328.
41.
IritaniN, SugimotoT, FukudaH.Gene expressions of leptin, insulin receptors and lipogenic enzymes are coordinately regulated by insulin and dietary fat in rats. J Nutr2000;130:1183–1188.
42.
PeirisAN, MuellerRA, SmithGA, StruveMF, KissebahAH.Splanchnic insulin metabolism in obesity: Influence of body fat distribution. J Clin Invest1986;78:1648–1657.
43.
BodenG.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes1997;46:3–10.
44.
SteinDT, EsserV, StevensonBE, LaneKE, WhitesideJH, DanielsMB, ChenS, McGarryJD.Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest1996;97:2728–2735.
45.
SteinDT, StevensonBE, ChesterMW, BasitM, DanielsMB, TurleySD, McGarryJD.The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest1997;100:398–403.
46.
DobbinsRL, ChesterMW, DanielsMB, McGarryJD, SteinDT.Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes1998;47:1613–1618.
47.
KomatsuM, YajimaH, YamadaS, KanekoT, SatoY, YamauchiK, HashizumeK, AizawaT.Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: Free fatty acids mimic ATP-sensitive K+channel-independent insulinotropic action of glucose. Diabetes1999;48:1543–1549.
48.
McGarryJD, DobbinsRL.Fatty acids, lipotoxicity and insulin secretion. Diabetologia1999;42:128–138.
BorkmanM, StorlienLH, PanDA, JenkinsAB, ChisholmDJ, CampbellLV.The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med1993;328:238–244.
51.
PanDA, LilliojaS, KriketosAD, MilnerMR, BaurLA, BogardusC, JenkinsAB, StorlienLH.Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes1997;46:983–988.
52.
DeFronzoRA, JacotE, JequierE, MaederE, WahrenJ, FelberJP.The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes1981;30:1000–1007.
53.
PagliassottiMJ, PanD, PrachP, KoppenhaferT, StorlienL, HillJO.Tissue oxidative capacity, fuel stores and skeletal muscle fatty acid composition in obesity-prone and obesity-resistant rats. Obes Res1995;3:459–464.
54.
OakesND, CamilleriS, FurlerSM, ChisholmDJ, KraegenEW.The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism1997;46:935–942.
55.
ShimabukuroM, KoyamaK, ChenG, WangMY, TrieuF, LeeY, NewgardCB, UngerRH.Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A1997;94:4637–4641.
56.
GoodpasterBH, ThaeteFL, SimoneauJA, KelleyDE.Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes1997;46:1579–1585.
57.
OakesND, BellKS, FurlerSM, CamilleriS, SahaAK, RudermanNB, ChisholmDJ, KraegenEW.Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes1997;46:2022–2028.
58.
PhillipsDI, CaddyS, IlicV, FieldingBA, FraynKN, BorthwickAC, TaylorR.Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects. Metabolism1996;45:947–950.
59.
GoodpasterBH, ThaeteFL, KelleyDE.Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr2000;71:885–892.
60.
SimoneauJA, ColbergSR, ThaeteFL, KelleyDE.Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J1995;9:273–278.
61.
MancoM, MingroneG, GrecoAV, CapristoE, GniuliD, De GaetanoA, GasbarriniG.Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism2000;49:220–224.
62.
GoodpasterBH, KelleyDE, WingRR, MeierA, ThaeteFL.Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes1999;48:839–847.
